Physician profile
Michael Guo
NPI 1780649517
$3,194.16
in general payments reported to CMS, 2019-2025
17 companies · $714 in 2025
The $714 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,365 · 2020: $125 · 2021: $175 · 2022: $171 · 2024: $645 · 2025: $714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,358.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $543.46 | 2019 | |
| Abbvie INC. | $423.21 | 2019-2024 | |
| Neurocrine Biosciences, INC. | $333.94 | 2021-2022 | |
| Novo Nordisk INC | $250.00 | 2019-2025 | Ozempic |
| Axsome Therapeutics, INC. | $220.34 | 2024-2025 | Symbravo, Auvelity |
| Alcon Vision LLC | $147.33 | 2025 | Hydrus Microstent |
| Lilly USA, LLC | $136.65 | 2019-2022 | |
| Glaxosmithkline, LLC. | $135.24 | 2024-2025 | Arexvy, Trelegy Ellipta |
| Amgen INC. | $125.00 | 2025 | Evenity |
| Astrazeneca Pharmaceuticals Lp | $125.00 | 2025 | Breztri |
| Angiodynamics, INC. | $125.00 | 2024 | Nanoknife |
| Merck Sharp & Dohme LLC | $125.00 | 2020 | |
| Intuitive Surgical, INC. | $123.45 | 2024 | |
| Novartis Pharmaceuticals Corporation | $117.34 | 2019 | |
| Boston Scientific Corporation | $116.38 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $90.00 | 2019 | |
| Acera Surgical, INC. | $56.82 | 2025 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Guo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.